TrialDrug design, development and therapy2017

Drug-drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer.

Gab-Jin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.